Quick Takeaways
- CVI Investments, Inc. filed SCHEDULE 13G/A for Bionano Genomics, Inc. Common Stock, $0.0001 par value per share (BNGO).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2025.
CVI Investments, Inc. - 31 Dec 2025 SCHEDULE 13G/A Report for Bionano Genomics, Inc. Common Stock, $0.0001 par value per share (BNGO)
- Filing Manager
- CVI Investments, Inc.
- Reporting Manager
- CVI Investments, Inc.
- Symbol
- BNGO
- Shares outstanding
- 11,408,192 shares
- Disclosed Ownership
- 1,129,411 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 14:46:39 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 22 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"CVI Investments, Inc. disclosed 9.9% ownership in Bionano Genomics, Inc. Common Stock, $0.0001 par value per share (BNGO) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 22 Sep 2025.
- Current filing was accepted on 17 Feb 2026, 14:46.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 9.9% | 1,129,411 | 0 | 1,129,411 | /s/ Sarah Travis | Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc. | |
| Heights Capital Management, Inc. | 9.9% | 1,129,411 | 0 | 1,129,411 | /s/ Sarah Travis | Sarah Travis, Assistant General Counsel and Assistant Secretary |